|
Navigating the Transition to End of Life Care in Patients with Cancer |
0.75 |
05/15/2019 - 12:00am to 03/01/2020 - 12:00am |
|
NCCN Guidelines® Insights - Acute Lymphoblastic Leukemia, Version 1.2019 |
1.00 |
05/10/2019 - 12:00am to 05/10/2020 - 12:00am |
|
NCCN Guidelines® Insights - B-Cell Lymphomas, Version 3.2019 |
1.00 |
06/10/2019 - 12:00am to 06/10/2020 - 12:00am |
|
NCCN Guidelines® Insights - Bladder Cancer, Version 5.2018 |
1.00 |
09/10/2018 - 12:00am to 09/10/2019 - 12:00am |
|
NCCN Guidelines® Insights - Breast Cancer, Version 3.2018 |
1.00 |
02/10/2019 - 12:00am to 02/10/2020 - 12:00am |
|
NCCN Guidelines® Insights - Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 |
1.00 |
11/10/2018 - 12:00am to 11/10/2019 - 12:00am |
|
NCCN Guidelines® Insights - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019 |
1.00 |
01/10/2019 - 12:00am to 01/10/2020 - 12:00am |
|
NCCN Guidelines® Insights - Hepatobiliary Cancers, Version 2.2019 |
1.00 |
04/10/2019 - 12:00am to 04/10/2020 - 12:00am |
|
NCCN Guidelines® Insights - Ovarian Cancer, Version 1.2019 |
1.00 |
08/10/2019 - 12:00am to 08/10/2020 - 12:00am |
|
NCCN Guidelines® Insights - Pancreatic Adenocarcinoma, Version 1.2019 |
1.00 |
03/10/2019 - 12:00am to 03/10/2020 - 12:00am |
|
NCCN Guidelines® Insights - Small Cell Lung Cancer, Version 2.2018 |
1.00 |
10/10/2018 - 12:00am to 10/10/2019 - 12:00am |
|
NCCN Guidelines® Insights - Survivorship, Version 2.2019 |
1.00 |
07/10/2019 - 12:00am to 07/10/2020 - 12:00am |
|
NCCN Guidelines® Insights - Thyroid Carcinoma, Version 2.2018 |
1.00 |
12/10/2018 - 12:00am to 12/10/2019 - 12:00am |
|
NCCN Guidelines® Updates: Breast Cancer - Multigene Testing in Breast Cancer |
0.32 |
05/15/2019 - 12:00am to 03/01/2020 - 12:00am |
|
NCCN Guidelines® Updates: Breast Cancer - Treatment of HR-Positive, HER-Negative Advanced Breast Cancer |
0.35 |
05/15/2019 - 12:00am to 03/01/2020 - 12:00am |
Facebook
Twitter
LinkedIn
Forward